COMP <GO>
KRSA vs AAPG // FREE CASH FLOW YIELD
Korsana Biosciences Inc. (NASDAQ) VS. Ascentage Pharma Group International American Depository Shares (NASDAQ) • 15-METRIC TALLY: KRSA 1
— AAPG 1
■ METRIC PARITY
LAST: $30.22 (+0.37%) • MKT CAP: $1.38B
fcf-yield
-0.24%
LAST: $14.88 (-0.70%) • MKT CAP: $1.39B
fcf-yield
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRSA VS. AAPG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KRSA | AAPG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -5.70% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -0.24% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 3.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.6 | 42.1 | +3.50 | KRSA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.38B | $1.39B | -$12.5M | AAPG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KRSA REV | AAPG REV | KRSA GROSS % | AAPG GROSS % | KRSA FCF | AAPG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.1M | — | — | — | -$3.3M | — |
| FY 2024 | $2.0M | — | — | — | -$4.3M | — |
| FY 2023 | $0 | — | — | — | -$21.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRSA // BETA —
AAPG // BETA —